We demonstrate here that AAV-mediated MICT1 administration to diet-induced or genetically obese mice can decrease adiposity and insulin resistance, revealing its therapeutic potential in obesity and insulin resistance. The gene discussed is CLMB; the disease is obesity due to melanocortin 4 receptor deficiency.